Plain-English translation of NCT07662356 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This research study invites people with obesity who are undergoing weight loss surgery to participate in learning more about nonalcoholic fatty liver disease (NAFLD). During your scheduled surgery, researchers will collect a small sample of liver tissue to examine under a microscope and study how the disease develops. The study will also track your health measurements before and after surgery to identify warning signs that predict how severe your liver disease might become.
Fatty liver disease is very common worldwide, but doctors still have many unanswered questions about why it develops, how it gets worse, and what the best treatments are. This study aims to fill those gaps by studying real patients and identifying early warning signs that could help prevent serious liver damage in the future.
You likely qualify if…
You likely don't qualify if…
If you enroll, you will have your standard weight loss surgery as planned, but during the operation, the surgeon will take a small liver tissue sample for examination. Before and after your surgery, you'll complete blood tests, physical exams, and questionnaires to assess your overall health and liver function. The study team will follow your health progress over time to see how your liver improves or changes following surgery.
AI-generated summary from trial data · Jul 8, 2026 · Not medical advice
Hong Kong